Education
About Us
Working with TipRanks
Follow Us
ENDRA Life Sciences Inc (NDRA)
NASDAQ:NDRA
NDRA Stock Chart & Stats
Day’s Range― - ―
52-Week Range$2.90 - $128.64
Previous CloseN/A
Volume13.45K
Average Volume (3M)3.33M
Market Cap
$3.86M
Enterprise Value$808.52K
Total Cash (Recent Filing)$2.06M
Total Debt (Recent Filing)$587.30K
Price to Earnings (P/E)―
Beta1.00
Next Earnings
Aug 18, 2025EPS Estimate
-2.27Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.86
Shares Outstanding752,755
10 Day Avg. Volume79,740
30 Day Avg. Volume3,328,779
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap0.21
Enterprise Value/Revenue3.82
Enterprise Value/Gross Profit14.52
Enterprise Value/Ebitda-0.10
Forecast
1Y Price Target
$46.00Price Target Upside979.81% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Bulls Say, Bears Say
Bulls Say
Market PotentialThe company's focus on early detection and monitoring of Steatotic Liver Disease opens up a large market opportunity.
Product InnovationThe launch of the TAEUS platform offers a new way for clinicians to visualize tissue composition and temperature, potentially revolutionizing point-of-care diagnostics.
Bears Say
Financial PerformanceENDRA currently generates no revenues as it is in the late stage of medical device development and early stage of commercialization.
ENDRA Life Sciences News
NDRA FAQ
What was ENDRA Life Sciences Inc’s price range in the past 12 months?
ENDRA Life Sciences Inc lowest stock price was $2.90 and its highest was $128.64 in the past 12 months.
What is ENDRA Life Sciences Inc’s market cap?
ENDRA Life Sciences Inc’s market cap is $3.86M.
When is ENDRA Life Sciences Inc’s upcoming earnings report date?
ENDRA Life Sciences Inc’s upcoming earnings report date is Aug 18, 2025 which is in 10 days.
How were ENDRA Life Sciences Inc’s earnings last quarter?
ENDRA Life Sciences Inc released its earnings results on May 15, 2025. The company reported -$1.86 earnings per share for the quarter, missing the consensus estimate of N/A by -$1.86.
Is ENDRA Life Sciences Inc overvalued?
According to Wall Street analysts ENDRA Life Sciences Inc’s price is currently Undervalued.
Does ENDRA Life Sciences Inc pay dividends?
ENDRA Life Sciences Inc does not currently pay dividends.
What is ENDRA Life Sciences Inc’s EPS estimate?
ENDRA Life Sciences Inc’s EPS estimate is -2.27.
How many shares outstanding does ENDRA Life Sciences Inc have?
ENDRA Life Sciences Inc has 752,755 shares outstanding.
What happened to ENDRA Life Sciences Inc’s price movement after its last earnings report?
ENDRA Life Sciences Inc reported an EPS of -$1.86 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 0.623%.
Which hedge fund is a major shareholder of ENDRA Life Sciences Inc?
Currently, no hedge funds are holding shares in NDRA
Company Description
ENDRA Life Sciences Inc
ENDRA Life Sciences (NDRA) is a medical technology company that operates in the healthcare sector. The company is focused on developing innovative diagnostic tools, particularly in the field of liver disease. ENDRA's flagship product is the Thermo Acoustic Enhanced Ultrasound (TAEUS) system, which aims to provide a cost-effective and non-invasive solution for assessing liver fat content, aiding in the management of conditions such as non-alcoholic fatty liver disease (NAFLD). The TAEUS system is designed to work alongside standard ultrasound systems, enhancing their capabilities with ENDRA's proprietary technology.
NDRA Stock 12 Month Forecast
Average Price Target
$46.00
▲(979.81% Upside)
Technical Analysis
Ownership Overview
21.55% Insiders
0.10% Mutual Funds
― Other Institutional Investors
78.35% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---